Incidence and Risk Factors for Placenta Accreta/Increta/Percreta in the UK: A National Case-Control Study
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Placenta accreta/increta/percreta is associated with major pregnancy complications and is thought to be becoming more common. The aims of this study were to estimate the incidence of placenta accreta/increta/percreta in the UK and to investigate and quantify the associated risk factors. METHODS: A national case-control study using the UK Obstetric Surveillance System was undertaken, including 134 women diagnosed with placenta accreta/increta/percreta between May 2010 and April 2011 and 256 control women. RESULTS: The estimated incidence of placenta accreta/increta/percreta was 1.7 per 10,000 maternities overall; 577 per 10,000 in women with both a previous caesarean delivery and placenta praevia. Women who had a previous caesarean delivery (adjusted odds ratio (aOR) 14.41, 95%CI 5.63-36.85), other previous uterine surgery (aOR 3.40, 95%CI 1.30-8.91), an IVF pregnancy (aOR 32.13, 95%CI 2.03-509.23) and placenta praevia diagnosed antepartum (aOR 65.02, 95%CI 16.58-254.96) had raised odds of having placenta accreta/increta/percreta. There was also a raised odds of placenta accreta/increta/percreta associated with older maternal age in women without a previous caesarean delivery (aOR 1.30, 95%CI 1.13-1.50 for every one year increase in age). CONCLUSIONS: Women with both a prior caesarean delivery and placenta praevia have a high incidence of placenta accreta/increta/percreta. There is a need to maintain a high index of suspicion of abnormal placental invasion in such women and preparations for delivery should be made accordingly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The major risk factors for placenta accreta spectrum are history of accreta in a previous pregnancy, previous caesarean delivery and other uterine surgery, including repeated endometrial curettage.”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [113]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overall, the aOR for placenta accreta spectrum after previous uterine surgery is 3.40 (95% CI 1.30-8.91).113”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [113]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Advanced maternal age (35 years or more) in women without a previous caesarean section increases the aOR by 1.30 (95% CI 1.13-1.50)for every 1-year increase in age.113”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [113]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“All epidemiological studies of the last 2 decades have shown a direct association between the increase in caesarean deliveries and the incidence of placenta accreta spectrum (abnormally adherent and invasive placenta) in subsequent pregnancies worldwide.[111][112][113][114][115][116][117][118][119][120][121]”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [113]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other additional risk factors include maternal age 110,113,117,120 and ART, in particular in vitro fertilisation.113,120,122-125”
From Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a (2019) · cites this paper as [113]
Experimental — accuracy not yet measured
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maternal Morbidity Associated With Multiple Repeat Cesarean Deliveries
Silver, R. M., Landon, M. B., Rouse, D. J., Leveno, K. J., Spong, C. Y., Thom, E. A., Moawad, A. H., Caritis, S. N., Harper, M., Wapner, R. J., et al. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000219750.79480.84 · Cited by 1,909
Abnormal placentation: Twenty-year analysis
Wu, S., Kocherginsky, M., & Hibbard, J. U. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.074 · Cited by 1,331
Clinical risk factors for placenta previa–placenta accreta
Miller, D. A., Chollet, J. A., & Goodwin, T. M. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70463-0 · Cited by 1,106
Placenta Previa, Placenta Accreta, and Vasa Previa
Oyelese, Y., & Smulian, J. C. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000207559.15715.98 · Cited by 975
Placenta previa/accreta and prior cesarean section.
Clark, S. L., Koonings, P. P., & Phelan, J. P. (1985) · PubMed · Cited by 712
(2001) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 434
Placenta previa-accreta: Risk factors and complications
Usta, I. M., Hobeika, E. M., Abu Musa, A. A., Gabriel, G. E., & Nassar, A. H. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.06.037 · Cited by 429
Vaginal birth after cesarean: new insights.
Guise, J., Eden, K., Emeis, C. L., Denman, M. A., Marshall, N., Fu, R., Janik, R., Nygren, P., Walker, M., & McDonagh, M. S. (2010) · PubMed · Cited by 425
Placenta Accreta—Summary of 10 Years: A Survey of 310 Cases
Gielchinsky, Y., Rojansky, N., Fasouliotis, S. J., & Ezra, Y. (2002) · Placenta · doi:10.1053/plac.2001.0764 · Cited by 376
A prospective national study of acute fatty liver of pregnancy in the UK
Knight, M., Nelson-Piercy, C., Kurinczuk, J. J., Spark, P., & Brocklehurst, P. (2008) · Gut · doi:10.1136/gut.2008.148676 · Cited by 376
Self-citation
Cited by
Silver, R. M., & Branch, D. W. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1709324 · Cited by 511
Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a
Jauniaux, E., Alfirevic, Z., Bhide, A., Belfort, M., Burton, G., Collins, S., Dornan, S., Jurkovic, D., Kayem, G., Kingdom, J., et al. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15306 · Cited by 506
“7 per 10 000 women overall to 577 per 10 000 in women with both a previous caesarean section and placenta praevia.(113) Evidence level 2+”
BackgroundFIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology,
Jauniaux, E., Chantraine, F., Silver, R. M., Langhoff‐Roos, J., & Panel, F. T. F. P. A. D. A. M. E. C. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12407 · Cited by 498
D'Antonio, F., Iacovella, C., & Bhide, A. (2013) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.13194 · Cited by 398
Thurn, L., Lindqvist, P., Jakobsson, M., Colmorn, L., Klungsoyr, K., Bjarnadóttir, R., Tapper, A., Børdahl, P., Gottvall, K., Petersen, K., et al. (2016) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13547 · Cited by 367
FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening,
Jauniaux, E., Bhide, A., Kennedy, A., Woodward, P., Hubinont, C., Collins, S., & Panel, F. T. F. P. A. D. A. M. E. C. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12408 · Cited by 367
Fitzpatrick, K., Sellers, S., Spark, P., Kurinczuk, J., Brocklehurst, P., & Knight, M. (2014) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12405 · Cited by 357
Self-citationJauniaux, E., & Bhide, A. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.050 · Cited by 348
“The incidence of placenta accreta is directly linked with the increase in caesarean delivery.(13-19) The main additional factor for the risk of placenta accreta”
BackgroundRisk factors for placenta accreta: a large prospective cohort
Eller, A., Bardsley, T., Greene, T., Varner, M., Silver, R., & Bowman, Z. (2013) · American Journal of Perinatology · doi:10.1055/s-0033-1361833 · Cited by 224
Mogos, M. F., Salemi, J. L., Ashley, M., Whiteman, V. E., & Salihu, H. M. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2015.1034103 · Cited by 213
Conservative management of morbidly adherent placenta: expert review
Fox, K. A., Shamshirsaz, A. A., Carusi, D., Secord, A. A., Lee, P., Turan, O. M., Huls, C., Abuhamad, A., Simhan, H., Barton, J., et al. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.04.034 · Cited by 210
“Similar findings were reported by Fitzpatrick et al,12 in a retrospective cohort of 134 cases of MAP identified by the United Kingdom Obstetrical Surveillance System, which surveys 221 hospitals across the United Kingdom.”
ResultEpidemiology of placenta previa accreta: a systematic review and meta-analysis
Jauniaux, E., Grønbeck, L., Bunce, C., Langhoff-Roos, J., & Collins, S. L. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031193 · Cited by 200
Cryopreserved embryo transfer is an independent risk factor for placenta accreta
Kaser, D. J., Melamed, A., Bormann, C. L., Myers, D. E., Missmer, S. A., Walsh, B. W., Racowsky, C., & Carusi, D. A. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.01.021 · Cited by 188
The Placenta Accreta Spectrum: Epidemiology and Risk Factors
Carusi, D. A. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000391 · Cited by 183
Baldwin, H. J., Patterson, J. A., Nippita, T. A., Torvaldsen, S., Ibiebele, I., Simpson, J. M., & Ford, J. B. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002434 · Cited by 147
Knight, M. (2018) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-2apkxdbxx · Cited by 169
Self-citationPlacenta Accreta Spectrum Disorders: Challenges, Risks, and Management Strategies
Morlando, M., & Collins, S. (2020) · International Journal of Women's Health · doi:10.2147/ijwh.s224191 · Cited by 165
Thomson, K., Moffat, M., Arisa, O., Jesurasa, A., Richmond, C., Odeniyi, A., Bambra, C., Rankin, J., Brown, H., Bishop, J., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-042753 · Cited by 154
Farquhar, C. M., Li, Z., Lensen, S. F., McLintock, C., Pollock, W., Peek, M. J., Ellwood, D. A., Knight, M., Homer, C., Vaughan, G. A., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017713 · Cited by 146
“More recently, the incidence of placenta accreta reported in the national United Kingdom Obstetric Surveillance System (UKOSS) was 17/100 000 women giving birth, from cases collected over a 12-month period in 2010– 2011.(19) Both UKOSS and AMOSS are case–control studies that employed national active surveillance of ca…”
BackgroundResultSelf-citationAn update on the risk factors for and management of obstetric haemorrhage
Sebghati, M., & Chandraharan, E. (2017) · Women s Health · doi:10.1177/1745505717716860 · Cited by 141
New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders
Jauniaux, E., Hussein, A. M., Fox, K. A., & Collins, S. L. (2019) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2019.04.006 · Cited by 110
“7 per 10,000 to 577 per 10,000 births in women presenting with a placenta previa and a prior CD (19).”
BackgroundJauniaux, E. R. M., Kingdom, J. C., & Silver, R. M. (2020) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.06.007 · Cited by 137
Accuracy of Ultrasonography and Magnetic Resonance Imaging in the Diagnosis of Placenta Accreta
Riteau, A.-S., Tassin, M., Chambon, G., Le Vaillant, C., de Laveaucoupet, J., Quéré, M.-P., Joubert, M., Prevot, S., Philippe, H.-J., & Benachi, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094866 · Cited by 112
“Identified risk factors include surgery, placenta previa and previous cesarean section [1,2].”
BackgroundRisk factors for abnormally invasive placenta: a systematic review and meta-analysis
Iacovelli, A., Liberati, M., Khalil, A., Timor-Trisch, I., Leombroni, M., Buca, D., Milani, M., Flacco, M. E., Manzoli, L., Fanfani, F., et al. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1493453 · Cited by 110
“Upson [41] 2013 Ireland Retrospective 2005–2010 All deliveries 403,602 357 403,245 Fitzpatrick [42] 2012 UK Retrospective 2010–2011 All women with AIP versus all women with no AIP 390 134 256”
BackgroundInfluentialNo. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders
Hobson, S. R., Kingdom, J. C., Murji, A., Windrim, R. C., Carvalho, J. C. A., Singh, S. S., Ziegler, C., Birch, C., Frecker, E., Lim, K. I., et al. (2019) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2018.12.004 · Cited by 132
Creanga, A. A., Bateman, B. T., Butwick, A. J., Raleigh, L., Maeda, A., Kuklina, E., & Callaghan, W. M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.05.002 · Cited by 130
Carrillo, A. P., & Chandraharan, E. (2019) · Women s Health · doi:10.1177/1745506519878081 · Cited by 130
Fitzpatrick, K., Tuffnell, D. J., Kurinczuk, J. J., & Knight, M. (2015) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13300 · Cited by 126
Self-citationGelany, S. E., Mosbeh, M., Ibrahim, E. M., Mohammed, M., Khalifa, E. M., Abdelhakium, A. K., Yousef, A. M., Hassan, H., Goma, K., Alghany, A. A., et al. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2466-5 · Cited by 123
Sentilhes, L., Seco, A., Azria, É., Beucher, G., Bonnet, M., Branger, B., Carbillon, L., Chiesa-Dubruille, C., Crenn‐Hébert, C., Dreyfus, M., et al. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.12.013 · Cited by 125
What we know about placenta accreta spectrum (PAS)
Liu, X., Wang, Y., Wu, Y., Zeng, J., Yuan, X., Tong, C., & Qi, H. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.02.001 · Cited by 121
Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section
Higgins, M. F., Monteith, C., Foley, M., & O’Herlihy, C. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.08.030 · Cited by 120
“In a national case control study reviewing all cases in the UK between 2009 and 2010, the rate of placenta accreta was 9/10,000 previous caesarean deliveries: their definition also included women with ‘‘abnormally adherent placenta requiring active management’’ [13].”
BackgroundHuque, S., Roberts, I., Fawole, B., Chaudhri, R., Arulkumaran, S., & Shakur‐Still, H. (2018) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-018-1829-7 · Cited by 116
“Risk factors for placenta accreta include previous caesarean section, other previous uterine surgery and advanced maternal age [25].”
BackgroundRomeo, V., Ricciardi, C., Cuocolo, R., Stanzione, A., Verde, F., Sarno, L., Improta, G., Mainenti, P. P., D'Armiento, M., Brunetti, A., et al. (2019) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2019.05.017 · Cited by 113
In vitro fertilization as an independent risk factor for placenta accreta spectrum
Salmanian, B., Fox, K. A., Arian, S. E., Erfani, H., Clark, S. L., Aagaard, K. M., Detlefs, S. E., Aalipour, S., Espinoza, J., Nassr, A. A., et al. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.04.026 · Cited by 112
Androgens and endometrium: new insights and new targets
Simitsidellis, I., Saunders, P. T. K., & Gibson, D. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.022 · Cited by 107
Development of placental abnormalities in location and anatomy
Jansen, C. H. J. R., Kastelein, A. W., Kleinrouweler, C. E., van Leeuwen, E., de Jong, K. H., Pajkrt, E., & Noorden, C. J. F. V. (2020) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13834 · Cited by 106
Ueno, Y. R., Kitajima, K., Kawakami, F., Maeda, T., Suenaga, Y., Takahashi, S., Matsuoka, S., Tanimura, K., Yamada, H., Ohno, Y., et al. (2013) · European Radiology · doi:10.1007/s00330-013-3076-7 · Cited by 105
Effect of site of placentation on pregnancy outcomes in patients with placenta previa
Jing, L., Wei, G., Mengfan, S., & Yanyan, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200252 · Cited by 103
Einerson, B. D., Gilner, J. B., & Zuckerwise, L. C. (2023) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000005229 · Cited by 100
Baldwin, H. J., Patterson, J. A., Nippita, T. A., Torvaldsen, S., Ibiebele, I., Simpson, J. M., & Ford, J. B. (2017) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13201 · Cited by 88
“Evidence for a link between IVF and AIP in the literature is limited by low numbers (1) and lack of adjustment for confounding factors (particularly maternal age) (23,24).”
BackgroundResultColmorn, L. B., Petersen, K. B., Jakobsson, M., Lindqvist, P. G., Klungsoyr, K., Källen, K., Bjarnadottir, R. I., Tapper, A., Børdahl, P. E., Gottvall, K., et al. (2015) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12639 · Cited by 77
“showed increased maternal age and previous CS to be risk factors for placenta accreta or percreta, but did not find any relation between BMI or multiparity (24).”
BackgroundA new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta
Jauniaux, E., Hussein, A. M., Zosmer, N., Elbarmelgy, R. M., Elbarmelgy, R. A., Shaikh, H., & Burton, G. J. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.11.1246 · Cited by 83
Genetics and Epigenetics of Infertility and Treatments on Outcomes
Pisarska, M. D., Chan, J. L., Lawrenson, K., Gonzalez, T. L., & Wang, E. T. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01869 · Cited by 88
Placenta Accreta Spectrum Without Placenta Previa
Carusi, D. A., Fox, K. A., Lyell, D. J., Perlman, N. C., Aalipour, S., Einerson, B. D., Belfort, M. A., Silver, R. M., & Shamshirsaz, A. A. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003970 · Cited by 84
Jauniaux, E. R. M., Aplin, J., Fox, K. A., Afshar, Y., Hussein, A. M., Jones, C. J. P., & Burton, G. J. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00624-3 · Cited by 81
“Large population-based studies using the national (UK) 18 or regional (Nordic) 20 Obstetric Surveillance Systems found that the incidence of PAS increases significantly (odds ratio of 290–600) in pregnant patients with both a previous caesarean delivery and placenta previa compared with pregnancies…”
InfluentialPlacental Implantation Disorders
Jauniaux, E. R. M., Moffett, A., & Burton, G. J. (2019) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2019.10.002 · Cited by 80
Fitzpatrick, K. E., van den Akker, T., Bloemenkamp, K. W. M., Deneux‐Tharaux, C., Krištúfková, A., Li, Z., Schaap, T. P., Sullivan, E. A., Tuffnell, D. J., & Knight, M. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002962 · Cited by 78
Self-citationAccuracy of ultrasound in antenatal diagnosis of placental attachment disorders
Pilloni, E., Alemanno, M. G., Gaglioti, P., Sciarrone, A., Garofalo, A., Biolcati, M., Botta, G., Viora, E., & Todros, T. (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14893 · Cited by 66
Placenta accreta spectrum-a catastrophic situation in obstetrics
Pegu, B., Chitra, T., Nayak, D., & Subbaiah, M. (2021) · Obstetrics & Gynecology Science · doi:10.5468/ogs.20345 · Cited by 74
“Recently, with the advent of in vitro fertilization (IVF) and advancements in cryopreservation techniques, cryopreserved embryo transfer (CET) has been proposed as an additional risk factor for PAS [16-18].”
BackgroundMorbidly adherent placenta: the need for standardization
Bhide, A., Sebire, N. J., Abuhamad, A., Acharya, G., & Silver, R. M. (2017) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17417 · Cited by 71
Hussein, A. M., Elbarmelgy, R. M., Elbarmelgy, R. M., Thabet, M. M., & Jauniaux, E. R. M. (2021) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23732 · Cited by 70
Knight, M., Acosta, C. D., Brocklehurst, P., Cheshire, A., Fitzpatrick, K. E., Hinton, L., Jokinen, M., Kemp, B., Kurinczuk, J. J., Lewis, G., et al. (2016) · Programme Grants for Applied Research · doi:10.3310/pgfar04090 · Cited by 70
“0001 Previous or pre-existing medical condition No 129 (56) 328 (72) 1 Yes 101 (44) 126 (28) 2.”
Self-citationChen, L., Wang, X., Wang, H., Li, Q., Shan, N., & Qi, H. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2175-0 · Cited by 69
Perinatal assessment of complex cesarean delivery: beyond placenta accreta spectrum
Jauniaux, E. R. M., Fox, K. A., Einerson, B. D., Hussein, A. M., Hecht, J. L., & Silver, R. M. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.02.021 · Cited by 66
Prise en charge des placenta praevia et accreta
Kayem, G., & Keïta, H. (2014) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2014.10.007 · Cited by 66
“[3] Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M.”
InfluentialClinical profiles of placenta accreta spectrum: the PACCRETA population‐based study
Kayem, G., Seco, A., Beucher, G., Dupont, C., Branger, B., Crenn‐Hébert, C., Huissoud, C., Fresson, J., Winer, N., Langer, B., et al. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16647 · Cited by 63
Soro, M.-A. P., Denys, A., de Rham, M., & Baud, D. (2017) · European Radiology · doi:10.1007/s00330-016-4395-2 · Cited by 62
“7 per 10,000 deliveries in the UK [87]).”
BackgroundUterine body placenta accreta spectrum: A detailed literature review
Badr, D. A., Hassan, J. A., Wehbe, G. S., & Ramadan, M. K. (2020) · Placenta · doi:10.1016/j.placenta.2020.04.005 · Cited by 61
Kayem, G., Seco, A., Vendittelli, F., Crenn‐Hébert, C., Dupont, C., Branger, B., Huissoud, C., Fresson, J., Winer, N., Langer, B., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-56964-9 · Cited by 62
Hussein, A. M., Fox, K. A., Bhide, A., Elbarmelgy, R. A., Elbarmelgy, R. M., Thabet, M. M., & Jauniaux, E. R. M. (2022) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17286 · Cited by 59
Cegolon, L., Mastrangelo, G., Maso, G., Pozzo, G. D., Ronfani, L., Cegolon, A., Heymann, W. C., & Barbone, F. (2020) · Scientific Reports · doi:10.1038/s41598-019-57037-y · Cited by 59
Knight, M. (2017) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-jndy9m5rd · Cited by 58
Self-citationDepartment of Obstetrics and Gynaecology, Q. E. H., Cheng, K. K., & Lee, M. M. (2015) · Hong Kong Medical Journal · doi:10.12809/hkmj154599 · Cited by 57
The urologist's role in multidisciplinary management of placenta percreta
Norris, B. L., Everaerts, W., Posma, E., Murphy, D. G., Umstad, M. P., Costello, A. J., Wrede, C. D., & Kearsley, J. (2016) · BJU International · doi:10.1111/bju.13332 · Cited by 56
Modest, A. M., Toth, T. L., Johnson, K. M., & Shainker, S. A. (2020) · American Journal of Perinatology · doi:10.1055/s-0040-1713887 · Cited by 56
Pregnancy after endometrial ablation: a systematic review
Kohn, J. R., Shamshirsaz, A., Popek, E. J., Guan, X., Belfort, M., & Fox, K. (2017) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14854 · Cited by 55
Ethnic Variations in Severe Maternal Morbidity in the UK– A Case Control Study
Nair, M., Kurinczuk, J. J., & Knight, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095086 · Cited by 54
“The cases included in this analysis were women who were reported to have one of the following ten conditions of severe maternal morbidity directly attributable to pregnancy causes: antenatal pulmonary embolism [8], eclampsia [9], acute fatty liver of pregnancy (AFLP) [10], amniotic fluid embolism (AFE) [7], peripartum…”
BackgroundSelf-citationMucio, B. D., Serruya, S. J., Alemán, A., Castellano, G., & Sosa, C. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12948 · Cited by 54
Sugai, S., Yamawaki, K., Sekizuka, T., Haino, K., Yoshihara, K., & Nishijima, K. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.101027 · Cited by 52
Laban, M., Ibrahim, E. A.-S., Elsafty, M. S. E., & Hassanin, A. S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.08.015 · Cited by 52
“7/10,000 in overall pregnant ladies and increasing to 577/10,000 in women with placenta previa and previous cesarean sections [5].”
BackgroundRomeo, V., Verde, F., Sarno, L., Migliorini, S., Petretta, M., Mainenti, P. P., D'Armiento, M. R., Guida, M., Brunetti, A., & Maurea, S. (2021) · La radiologia medica · doi:10.1007/s11547-021-01348-6 · Cited by 52
Zeng, C., Yang, M., Ding, Y., Duan, S., & Zhou, Y. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12418 · Cited by 51
Placenta accreta spectrum disorder: updates on anesthetic and surgical management strategies
Einerson, B. D., & Weiniger, C. F. (2021) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2021.102975 · Cited by 52
Korosec, S., Ban Frangez, H., Verdenik, I., Kladnik, U., Kotar, V., Virant-Klun, I., & Vrtacnik Bokal, E. (2014) · BioMed Research International · doi:10.1155/2014/431797 · Cited by 50
Etiopathogenesis and risk factors for placental accreta spectrum disorders
Ali, H., & Chandraharan, E. (2020) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.07.006 · Cited by 50
Assisted vaginal birth in 21st century: current practice and new innovations
Bahl, R., Hotton, E. J., Crofts, J. F., & Draycott, T. J. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.12.305 · Cited by 48
Ayati, S., Pourali, L., Pezeshkirad, M., Toosi, F. S., Nekooei, S., Shakeri, M. T., & Golmohammadi, M. S. (2017) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.15.4.225 · Cited by 46
“The risk factors for PAD are: placenta previa, prior uterine surgery such as cesarean section, myomectomy, Asherman syndrome, endometrial defects due to vigorous curettage, corneal resection, anterior placenta, smoking, hypertension, pregnancy induced via in vitro fertilization (IVF), subserosal and submucosal myoma,…”
BackgroundUpdates on the management of placenta accreta spectrum
Mascio, D. D., Calì, G., & D’Antonio, F. (2019) · Minerva Obstetrics and Gynecology · doi:10.23736/s0026-4784.18.04333-2 · Cited by 47
Booker, W. A., & Moroz, L. A. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.11.009 · Cited by 47
Sun, W., Duan, S., Xin, G., Xiao, J., Hong, F., Hong, H., Wu, Y., & Xu, Y. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.10.002 · Cited by 45
Coutinho, C. M., Giorgione, V., Noël, L., Liu, B., Chandraharan, E., Pryce, J. W., Frick, A., Thilaganathan, B., & Bhide, A. (2020) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23100 · Cited by 45
Uterine Transplantation: Review of Livebirths and Reproductive Implications
Jones, B. P., Kasaven, L. S., Vali, S., Saso, S., Jalmbrant, M., Bracewell‐Milnes, T., Thum, M., Quiroga, I., Friend, P. J., Díaz‐García, C., et al. (2020) · Transplantation · doi:10.1097/tp.0000000000003578 · Cited by 45
“The background risk of placenta accreta in women without previous cesarean section is 1 in 33 000.(136) However, the episode of rejection in the first trimester, at a time when the placenta is undergoing extensive vascular remodeling is likely to be significant.”
BackgroundRisk factors and clinical outcomes for placenta accreta spectrum with or without placenta previa
Ogawa, K., Jwa, S. C., Morisaki, N., & Sago, H. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06189-2 · Cited by 44
“Based on previous studies, we considered the following variables available in our database as possible risk factors for placental accreta: conception method, maternal age, parity, history of previous miscarriage, and previous cesarean section [5, 7, 11, 13].”
BackgroundMethodBerezowsky, A., Pardo, J., Ben‐Zion, M., Wiznitzer, A., & Aviram, A. (2019) · Fetal Diagnosis and Therapy · doi:10.1159/000492829 · Cited by 42
The effect of placental location in cases of placenta accreta spectrum
Morgan, E. A., Sidebottom, A. C., Vacquier, M. C., Wunderlich, W. L., & Loichinger, M. H. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.07.028 · Cited by 42
Ornaghi, S., Maraschini, A., Donati, S., & on behalf of The Regional Obstetric Surveillance System Working Group (2021) · PLoS ONE · doi:10.1371/journal.pone.0252654 · Cited by 42
Einerson, B. D., Kennedy, A., Silver, R. M., Branch, D. W., Comstock, J. M., & Woodward, P. J. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005075 · Cited by 42
Kong, F., Fu, Y., Shi, H., Li, R., Zhao, Y., Wang, Y., & Qiao, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.924070 · Cited by 42
Carrillo, A. P., Bhide, A., Moore, J., Hartopp, R., Belli, A., Arulkumaran, S., Thilaganathan, B., & Chandraharan, E. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12990 · Cited by 41
Bulka, C. M., Everson, T. M., Burt, A., Marsit, C. J., Karagas, M. R., Boyle, K. E., Niemiec, S., Kechris, K. J., Davidson, E., Yang, I. V., et al. (2023) · Epigenetics · doi:10.1080/15592294.2023.2179726 · Cited by 40
“Abnormalities of the placenta have been proposed to underlie a myriad of pregnancy complications, including preterm labour [3], preeclampsia [4], gestational diabetes [5], placenta accreta [6], placental abruption [7], and intrauterine growth restriction [8], together affecting as many as 1 in 10 pregnancies.”
BackgroundMode of first delivery and severe maternal complications in the subsequent pregnancy
Colmorn, L. B., Krebs, L., Klungsøyr, K., Jakobsson, M., Tapper, A.-M., Gissler, M., Lindqvist, P. G., Källen, K., Gottvall, K., Bordahl, P. E., et al. (2017) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.13163 · Cited by 35
McCall, S. J., Deneux‐Tharaux, C., Sentilhes, L., Ramakrishnan, R., Collins, S. L., Seco, A., Kurinczuk, J. J., Knight, M., & Kayem, G. (2022) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17169 · Cited by 38
Self-citationA View From the UK: The UK and Ireland Confidential Enquiry into Maternal Deaths and Morbidity
KNIGHT, M., & TUFFNELL, D. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000352 · Cited by 37
“Previous caesarean birth is a known risk factor for abnormally invasive placenta [8], and it is of concern that there is early evidence in the UK of an increase in maternal deaths from haemorrhage in association with abnormally invasive placenta [1].”
BackgroundSelf-citationObstetric Outcomes of Pregnancy After Uterine Artery Embolization
Jitsumori, M., Matsuzaki, S., Endo, M., Hara, T., Tomimatsu, T., Matsuzaki, S., Miyake, T., Takiuchi, T., Kakigano, A., Mimura, K., et al. (2020) · International Journal of Women s Health · doi:10.2147/ijwh.s236443 · Cited by 37
Gulino, F. A., Guardo, F. D., Zambrotta, E., Gregorio, L. M. D., Miranda, A., Capriglione, S., & Palumbo, M. A. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4780-y · Cited by 37
Management of patients with suspected placenta accreta spectrum
Reale, S. C., & Farber, M. K. (2021) · BJA Education · doi:10.1016/j.bjae.2021.10.002 · Cited by 37
Berhan, Y., & Urgie, T. (2020) · Ethiopian Journal of Health Sciences · doi:10.4314/ejhs.v30i2.16 · Cited by 36
“Its incidence was much higher in women with placenta previa and/or scarred uterus (6,7).”
BackgroundPrediction Model for Massive Transfusion in Placenta Previa during Cesarean Section
Kang, J., Kim, H. S., Lee, E. B., Uh, Y., Han, K.-H., Park, E. Y., Lee, H. A., Kang, D. R., Chung, I.-B., & Choi, S. J. (2020) · Yonsei Medical Journal · doi:10.3349/ymj.2020.61.2.154 · Cited by 34
Teare, J., Evans, E., Belli, A., & Wendler, R. (2014) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2013.11.002 · Cited by 33
Metadata
- Authors
- Fitzpatrick, K. E., Sellers, S., Spark, P., Kurinczuk, J. J., Brocklehurst, P., & Knight, M.
- Affiliations
- University of Oxford (GB)
- University College London (GB)
- Corresponding author
- Knight, Marian
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-27
- Volume
- 7
- Issue
- 12
- Pages
- e52893
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3531337
- OpenAlex
- W2084108532
- Cited by
- 463
- References
- 23
- Citations by year
- 2026: 10 · 2025: 33 · 2024: 44 · 2023: 59 · 2022: 40 · 2021: 60 · 2020: 38 · 2019: 48 · 2018: 37 · 2017: 30 · 2016: 12 · 2015: 19 · 2014: 17 · 2013: 13 · 2012: 1
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (RP-PG-0608-10038, Programme Grant RP-PG-0608-10038, 10038)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Keywords
- placenta accreta, placenta increta, placenta percreta, incidence, risk factors, previous cesarean section, placenta previa, previous uterine surgery, in vitro fertilization, maternal age, pregnancy complications
- MeSH terms
- Adult, Cesarean Section, Female, United Kingdom, Humans, Maternal Age, Placenta Accreta, Placenta Previa, Pregnancy, Risk Factors, Incidence, Odds Ratio, Case-Control Studies, Epidemiological Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
